Cargando…

Long-term use of bisphosphonates in osteoporosis

Detalles Bibliográficos
Autores principales:	Sadat-Ali, Mir, AlAnii, Fawaz M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556308/ https://www.ncbi.nlm.nih.gov/pubmed/28762444 http://dx.doi.org/10.15537/smj.2017.8.20748

Ejemplares similares

Stem-cell therapy for ovariectomy-induced osteoporosis in rats: a comparison of three treatment modalities
por: Sadat-Ali, Mir, et al.
Publicado: (2019)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017)

Can we suppress excessive post-surgical scar formation: A case report
por: Sadat-Ali, Mir, et al.
Publicado: (2023)

Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
por: Kamimura, Mikio, et al.
Publicado: (2019)

Maintenance Dose of Vitamin D: How Much Is Enough?
por: Sadat-Ali, Mir, et al.
Publicado: (2018)

Effect of Long-Term Use of Bisphosphonates on Forearm Bone: Atypical Ulna Fractures in Elderly Woman with Osteoporosis
por: Erdem, Yusuf, et al.
Publicado: (2016)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Vancomycin flushing syndrome in orthopaedic practice: A case report
por: Al-Anii, Fawaz M, et al.
Publicado: (2023)

GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
por: Hadji, P., et al.
Publicado: (2016)

Are we closing the gaps in the management of osteoporosis following fragility fractures of the femur?
por: Sadat-Ali, Mir, et al.
Publicado: (2019)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Osteoporosis in Saudi Arabia
por: Jawad, Ali S.
Publicado: (2016)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates
por: Gu, Tao, et al.
Publicado: (2016)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Treatment of Atypical Ulnar Fractures Associated with Long-Term Bisphosphonate Therapy for Osteoporosis: Autogenous Bone Graft with Internal Fixation
por: Shimada, Yohei, et al.
Publicado: (2017)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Vertebroplasty in osteoporosis-related vertebral fractures
por: Sadat-Ali, Mir
Publicado: (2008)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

The relationship between bisphosphonate use and demographic characteristics of male osteoporosis patients
por: Cevikoi, Alev, et al.
Publicado: (2011)

An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population
por: Sadat-Ali, Mir, et al.
Publicado: (2012)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
por: Newcomb, P A, et al.
Publicado: (2010)

Osteoporosis Not Millet-disease
por: Hinebauch, T. D.
Publicado: (1896)

Osteoporosis among male Saudi Arabs: a pilot study
por: Sadat-Ali, Mir, et al.
Publicado: (2006)

The Effects of Long-term Use of Nitrogen-containing Bisphosphonates on Fracture Healing
por: Begkas, Dimitrios, et al.
Publicado: (2019)

Early detected femoral neck insufficiency fracture in a patient treated with long-term bisphosphonate therapy for osteoporosis: A need for MRI
por: Seong, Yoon Jae, et al.
Publicado: (2020)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4u0pa6rkiksoslicsdqifeuk96